Beware the Air!
Why Particulate Matter Matters
Jump to

See related article, pages 716 – 726
The “Six Cities Study,” as it is affectionately known by epidemiologists, was published in 1993. This landmark study laid the groundwork for an association between ambient air particulate matter (ie, fine particulate matter [PM] or PM2.5 [particulate matter of 2.5 μm aerodynamic diameter or less]) and the risk of all cause mortality in the United States.1 Simply put, the message of the study was: “Air pollution kills.” Since then, a steady stream of studies has grown into a river of reports that collectively have swelled the banks of this initial association and have further specified that ischemic heart disease (cardiovascular disease [CVD]) is the single-most abundant cause of morbidity and mortality in this association.2,–,4 Analysis of more than 100 studies (>100 million people in 119 cities in the United States and Europe) show that for each 10 μg/m3 acute or chronic increase in PM2.5, there is a significant increase in relative risk of cardiovascular mortality (chronic relative risk, 1.06 to 1.76), indicating that PM, even at ambient levels, has negative health consequences.4 Moreover, chronic exposure to each 10 μg/m3 PM2.5 increase is associated with a 4 to 6% increase in CVD deaths, which translates to 800 000 deaths annually in the world (according to the World Health Organization), making PM exposure the 13th leading cause of CVD deaths4 and, thus, deserving of urgent scientific and social attention. Currently, researchers in the field of environmental cardiology5 are addressing at least 1 of 2 major unanswered questions regarding this association: (1) What constituent of inhaled PM2.5 is responsible for the association?; and (2) What is the mechanism by which inhaled PM2.5 can specifically affect cardiovascular disease risk?
In this issue of Circulation Research, Kampfrath et al address the latter “mechanistic question” and provide, for the first time, a biologically plausible mechanism that connects PM2.5 exposure with vascular inflammation and dysfunction.6 To do so, the group tracked oxidative changes induced in the lungs following chronic exposure to concentrated ambient PM2.5 (CAPs) to the terminal changes of vascular inflammation and dysfunction in the aortic wall and in several other systemic vascular beds as well, which ultimately increases risk for CVD (eg, promoting atherosclerosis, thrombosis). Although it is nearly cliché to read that inhaled particles (PM2.5, nanoparticles) induce “oxidative stress and/or lipid peroxidation” in the lungs and systemically and that this leads to cardiovascular inflammation and dysfunction, one finds in the present study of Kampfrath et al that “oxidative stress” has a molecular identity in the derivatives of oxidized phospholipid 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (oxPAPC), including 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC), a well-known constituent of oxidized low-density lipoprotein, which can directly activate endothelial cells and stimulate the release/production of interleukin-8 (KC in mice) via Toll-like receptor (TLR)4 and an associated protein.7,8 Nonetheless, POVPC (or a related lipid peroxidation product) generated in the lungs after PM2.5 exposure appears to touch off a positive-feedback response in the lungs that also involves TLR4 and NADPH oxidase, leading to enhanced superoxide production and mobilization of mononuclear cells (eg, F4/80+, LyG6+high, c-fms+ cells) from bone marrow into the circulation, lungs, and vascular wall, specifically into the perivascular adipose (Figure). The emphasis on this latter step whereby mononuclear (inflammatory) cells home to perivascular adipose is timely and, more importantly, provides a plausible link between a disparate number of stimuli (eg, CAPs, high-fat diet–induced obesity,9,10 metabolic syndrome and diabetes,11 angiotensin II infusion, and hypertension12) and vascular inflammation and vascular/endothelial dysfunction. Once a sufficient number of F4/80 (c-fms+ or LyG6+high) cells has homed to the vascular wall, there is a significant increase in NADPH oxidase– and perivascular-derived superoxide. Both the TLR4 and NADPH oxidase dependences of vascular inflammation were elegantly shown by Kampfrath et al, through chronic CAPs exposure of mice deficient in either the TLR4 or the NADPH oxidase subunit Nox2 (gp91phox−/−) proteins.6 It is worth noting, however, that various mechanistic steps were shown in different mouse strains.
Mechanism of PM2.5 induction of vascular inflammation. Ambient PM2.5 is selectively concentrated by the VACES and then inhaled. PM2.5 interacts with pulmonary cells and initiates lipid oxidation, generating oxPAPC and POVPC, which activate TLR4-dependent pathways including increased NADPH oxidase expression. Released cytokines and chemokines stimulate bone marrow–derived mononuclear cells (BMDCs especially Ly6C+high) to home to the perivascular adipose and increase vascular formation of NADPH oxidase–dependent superoxide, which contributes to endothelial activation and dysfunction. (Illustration credit: Cosmocyte/Ikumi Kayama.)
The significance of these findings extends beyond the important mechanistic insights. Exposure of normal, healthy mice to real world particle (CAPs) pollution demonstrates that this level of pollution is alone sufficient to induce systemic vascular inflammation/dysfunction without any additional stressor required (eg, angiotensin II infusion, high fat diet, “second hit”). Moreover, the level of PM2.5 exposure is relevant to human exposures. Mice were exposed for 6 h/d, 5 d/wk for 20 weeks using a versatile aerosol concentration enrichment system (VACES) to an average level of 92 μg/m3 PM2.5. This CAPs level is ≈9 times higher than the average ambient PM2.5 of 10 μg/m3 in Columbus, OH, whereas, the annual mean US National Ambient Air Quality Standards (NAAQS) for PM2.5 is 15 μg/m3. Because mice were exposed for only 6 h/d and not on weekends, overall exposure level is approximately equivalent to the annual US NAAQS and the World Health Organization annual mean PM2.5 of 10 μg/m3. The significance of this exposure condition is best appreciated when assessing daily and annual levels of PM2.5 in major cities around the globe, as in China,13,14 India,15 and eastern Europe.16 For example, daily average PM2.5 in Shanghai, China, is 56.4 μg/m3,13 with levels regularly exceeding 100 μg/m3 because of a confluence of traffic, coal burning, industry, and meteorologic conditions.14 Similarly, during a winter inversion event in the Wasatch Valley of Utah, PM2.5 significantly increased with peak levels reaching 150 μg/m3.17 Importantly, exposure to this elevated PM2.5 level significantly decreases the number of circulating endothelial progenitor cells17 in healthy young adults, indicating that acute PM2.5 exposure (as well as chronic) also initiates systemic vascular injury.18 Whether this striking acute event involves similar mechanisms as presented by Kampfrath et al6 (ie, lung oxidation, POVPC generation, TLR4 activation, and upregulation of NADPH oxidase) remains to be seen but provides, at minimum, evidence that circulating endothelial progenitor cells could be a useful “PM2.5 bellwether” for predicting vascular insult/dysfunction during PM2.5 exposures.
Like all good research, this study raises more questions than it answers. For example, in what cells does pulmonary oxPAPC or POVPC stimulate TLR4 (eg, lung macrophage, lung microvascular endothelial cells)? Similarly, it is not only possible but likely that additional products of oxPAPC, namely free, unsaturated aldehydes, such as 4-hydroxy-nonenal (HNE), are involved in inflammatory signaling. HNE is generated in equal molar amounts with POVPC following β-scission of lipid peroxides. Whereas POVPC is membrane-bound and saturated, HNE is far more reactive (α,β-unsaturated), has greater diffusive mobility, and induces a variety of proinflammatory, proliferative, and cytotoxic effects in vascular cells.19,–,22 In any case, the role of specific oxidized products generated in the lungs following PM2.5 exposure in activation of TLR4-dependent pathways remains an important question. Systemically, the signals that induce homing of mononuclear cells into the perivascular adipose and induce conversion of perivascular fat from benign regulator of vascular tone23 to an inflammatory organ24,25 are being identified and perivascular cytokines/chemokines appear to provide the requisite stimuli (eg, superoxide, NO, interleukin-6, tumor necrosis factor-α, vascular endothelial growth factor) for endothelial dysfunction, endothelial activation, adhesion molecule expression, and mononuclear cell retention. Finally, the specific component of PM2.5 that is responsible for “jump starting” the whole concerted activity is unidentified and remains an area of controversy. Many inhalation studies indicate that pulmonic and systemic effects of PM2.5 (or whole combustion exhaust) can be attributed to a particle fraction much smaller than 2.5 μm (eg, ultrafine or PM0.1 [<0.1 μm diameter] or nanoparticles)26,27 or even to nonparticulates/volatiles.28,–,31 Similarly, lipopolysaccharide can be a constituent of PM and can stimulate TLRs. In the present study, a VACES concentrates only ambient particles ≤2.5 μm diameter but not the ambient gases/volatiles, and, thus, the particulate fraction is clearly the trigger (noteworthy is that lipopolysaccharide levels were similar in lungs of air- and PM-exposed mice), but whether the PM2.5 or a smaller PM0.1 fraction (and what chemical constituent) is responsible remains a question.
Is the mystery solved regarding the mechanism how inhaled PM2.5 exposure stimulates vascular inflammation and injury? Well, probably not completely, but the present scenario laid out by Kampfrath et al6 connects findings from their study with many disparate human and animal epidemiological/exposure studies into a plausible story. Future studies will be required to elucidate exactly what constituent(s) of PM2.5 is (are) so prooxidant/toxic in the lung, how POVPC (or a related product) targets important cells, what specific signals regulated bone marrow–derived mononuclear cell trafficking to perivascular adipose, and whether these steps are ultimately activated in humans exposed chronically to PM2.5. One thing is clear: particulate matter matters!
Sources of Funding
The laboratory of D.J.C. is supported in part by grants from National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; and the Health Effects Institute.
Disclosures
None.
Footnotes
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
Non-standard Abbreviations and Acronyms
- CAP
- concentrated ambient particulate
- CVD
- cardiovascular disease
- HNE
- 4-hydroxy-nonenal
- oxPAPC
- 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine
- PM
- particulate matter
- PM2.5
- particulate matter of 2.5 μm aerodynamic diameter or less
- POVPC
- 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine
- TLR
- Toll-like receptor
- VACES
- versatile aerosol concentration enrichment system
- © 2011 American Heart Association, Inc.
References
- 1.↵
- 2.↵
- Pope CA III.,
- Burnett RT,
- Thurston GD,
- Thun MJ,
- Calle EE,
- Krewski D,
- Godleski JJ
- 3.↵
- Pope CA III.,
- Muhlestein JB,
- May HT,
- Renlund DG,
- Anderson JL,
- Horne BD
- 4.↵
- Brook RD,
- Rajagopalan S,
- Pope CA III.,
- Brook JR,
- Bhatnagar A,
- Diez-Roux AV,
- Holguin F,
- Hong Y,
- Luepker RV,
- Mittleman MA,
- Peters A,
- Siscovick D,
- Smith SC Jr.,
- Whitsel L,
- Kaufman JD
- 5.↵
- Bhatnagar A
- 6.↵
- Kampfrath T,
- Maiseyeu A,
- Ying Z,
- Shah Z,
- Deiuliis JA,
- Xu X,
- Kherada N,
- Brook RD,
- Reddy KM,
- Padture NP,
- Parthasarathy S,
- Chen LC,
- Moffatt-Bruce S,
- Sun Q,
- Morawietz H,
- Rajagopalan S
- 7.↵
- Walton KA,
- Cole AL,
- Yeh M,
- Subbanagounder G,
- Krutzik SR,
- Modlin RL,
- Lucas RM,
- Nakai J,
- Smart EJ,
- Vora DK,
- Berliner JA
- 8.↵
- Walton KA,
- Hsieh X,
- Gharavi N,
- Wang S,
- Wang G,
- Yeh M,
- Cole AL,
- Berliner JA
- 9.↵
- 10.↵
- 11.↵
- Marchesi C,
- Ebrahimian T,
- Angulo O,
- Paradis P,
- Schiffrin EL
- 12.↵
- Guzik TJ,
- Hoch NE,
- Brown KA,
- McCann LA,
- Rahman A,
- Dikalov S,
- Goronzy J,
- Weyand C,
- Harrison DG
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- O'Toole TE,
- Hellmann J,
- Wheat L,
- Haberzettl P,
- Lee J,
- Conklin DJ,
- Bhatnagar A,
- Pope CA III.
- 18.↵
- 19.↵
- Ruef J,
- Rao GN,
- Li F,
- Bode C,
- Patterson C,
- Bhatnagar A,
- Runge MS
- 20.↵
- 21.↵
- Whitsett J,
- Picklo MJ Sr.,
- Vasquez-Vivar J
- 22.↵
- Usatyuk PV,
- Parinandi NL,
- Natarajan V
- 23.↵
- Lohn M,
- Dubrovska G,
- Lauterbach B,
- Luft FC,
- Gollasch M,
- Sharma AM
- 24.↵
- 25.↵
- 26.↵
- Araujo JA,
- Barajas B,
- Kleinman M,
- Wang X,
- Bennett BJ,
- Gong KW,
- Navab M,
- Harkema J,
- Sioutas C,
- Lusis AJ,
- Nel AE
- 27.↵
- Nurkiewicz TR,
- Porter DW,
- Hubbs AF,
- Stone S,
- Chen BT,
- Frazer DG,
- Boegehold MA,
- Castranova V
- 28.↵
- 29.↵
- Campen MJ,
- Babu NS,
- Helms GA,
- Pett S,
- Wernly J,
- Mehran R,
- McDonald JD
- 30.↵
- Campen MJ,
- Lund AK,
- Doyle-Eisele ML,
- McDonald JD,
- Knuckles TL,
- Rohr AC,
- Knipping EM,
- Mauderly JL
- 31.↵
This Issue
Article Tools
- Beware the Air!Daniel J. ConklinCirculation Research. 2011;108:644-647, originally published March 17, 2011https://doi.org/10.1161/CIRCRESAHA.111.241174
Citation Manager Formats